In today’s session Agilent Technologies Inc (A) registered an unusually high (2,051) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the January, 2017 call, expecting serious A increase. With 2,051 contracts traded and 7154 open interest for the Jan, 17 contract, it seems this is a quite bullish bet. The option with symbol: A170120C00047500 closed last at: $0.59 or 9.3% up. About 362,667 shares traded hands. Agilent Technologies Inc (NYSE:A) has risen 9.13% since March 31, 2016 and is uptrending. It has outperformed by 6.61% the S&P500.
Agilent Technologies Inc (NYSE:A) Ratings Coverage
Out of 10 analysts covering Agilent Technologies (NYSE:A), 7 rate it a “Buy”, 0 “Sell”, while 3 “Hold”. This means 70% are positive. Agilent Technologies has been the topic of 21 analyst reports since August 14, 2015 according to StockzIntelligence Inc. The rating was maintained by BTIG Research on Friday, August 14 with “Buy”. The stock has “Buy” rating given by TheStreet on Tuesday, August 25. The rating was upgraded by Robert W. Baird to “Outperform” on Wednesday, December 9. As per Thursday, January 7, the company rating was initiated by Deutsche Bank. As per Thursday, August 18, the company rating was maintained by Cowen & Co. The company was maintained on Thursday, August 18 by Evercore. The stock of Agilent Technologies Inc (NYSE:A) earned “Buy” rating by BTIG Research on Friday, July 22. As per Thursday, August 18, the company rating was maintained by BTIG Research. The stock has “Outperform” rating given by Cowen & Co on Thursday, May 26. Goldman Sachs maintained Agilent Technologies Inc (NYSE:A) rating on Thursday, August 18. Goldman Sachs has “Buy” rating and $50 price target.
According to Zacks Investment Research, “Agilent Technologies is the world’s premier measurement company and a technology leader in communications, electronics, life sciences and chemical analysis. Agilent has two primary business segments: Bio-Analytical Measurement and Electronic Measurement.”
Insitutional Activity: The institutional sentiment decreased to 0.95 in Q2 2016. Its down 0.03, from 0.98 in 2016Q1. The ratio is negative, as 39 funds sold all Agilent Technologies Inc shares owned while 189 reduced positions. 48 funds bought stakes while 168 increased positions. They now own 266.26 million shares or 3.79% less from 276.75 million shares in 2016Q1.
Public Employees Retirement Association Of Colorado accumulated 0.03% or 70,162 shares. Lenox Wealth Mngmt reported 1,062 shares or 0.03% of all its holdings. Janney Montgomery Scott Ltd Company has 10,677 shares for 0.01% of their US portfolio. Moreover, Carroll Associates Inc has 0% invested in Agilent Technologies Inc (NYSE:A) for 352 shares. Assetmark Inc has 1,181 shares for 0% of their US portfolio. Ngam Advisors Limited Partnership accumulated 19,440 shares or 0.01% of the stock. Amica Mutual Insur Com accumulated 26,574 shares or 0.11% of the stock. Pioneer Inv Inc has invested 0.02% of its portfolio in Agilent Technologies Inc (NYSE:A). Cantab Capital Prns Limited Liability Partnership accumulated 5,343 shares or 0% of the stock. Toronto Dominion Natl Bank holds 0% or 1,902 shares in its portfolio. Chesley Taft And Assoc Limited Company last reported 12,325 shares in the company. Verition Fund Mgmt Ltd Liability Company has invested 0.06% of its portfolio in Agilent Technologies Inc (NYSE:A). Dai Ichi Life Insur Limited last reported 0.01% of its portfolio in the stock. The New York-based New York State Teachers Retirement Sys has invested 0.07% in Agilent Technologies Inc (NYSE:A). Rh Dinel Inv Counsel Inc last reported 12,235 shares in the company.
Insider Transactions: Since May 11, 2016, the stock had 0 buys, and 12 insider sales for $10.19 million net activity. 16,922 shares with value of $755,170 were sold by CULLEN JAMES on Monday, May 23. The insider McMullen Michael R. sold 124,411 shares worth $5.53 million. Kaltenbach Patrick sold $94,600 worth of Agilent Technologies Inc (NYSE:A) on Friday, September 30. Shares for $422,133 were sold by Gonsalves Rodney on Wednesday, May 18. KOH BOON HWEE also sold $252,503 worth of Agilent Technologies Inc (NYSE:A) shares. Grau Dominique sold $443,846 worth of stock. Doak Mark sold $833,319 worth of stock or 18,879 shares.
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The company has a market cap of $14.12 billion. The Firm serves the life sciences, diagnostics and applied chemical markets. It has a 29.94 P/E ratio. It has three business divisions: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business.
A Company Profile
Agilent Technologies, Inc., incorporated on May 4, 1999, provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Firm serves the life sciences, diagnostics and applied chemical markets. The Firm has three business divisions: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. The life sciences and applied markets business segment brings together the Company’s analytical laboratory instrumentation and informatics. The Company’s diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. The Company’s Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
More news for Agilent Technologies Inc (NYSE:A) were recently published by: Businesswire.com, which released: “Agilent Technologies and PureHoney Technologies to Develop New Applications …” on November 01, 2016. Finance.Yahoo.com‘s article titled: “Agilent Technologies to Host Webcast of Fourth-Quarter Fiscal Year 2016 …” and published on October 25, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.